Commenting on their vision, the Co-Founder and Managing Partner of Corridor Ventures, Kwamena Aidoo, commented that Connecting wearable device and electronic health records data has the potential to transform clinical research insights and evolve the way health and wellness care is administered across the globe. They continue, suggesting that Patientory sits at the forefront of this movement
Care may include: Comprehensive intake and health history Lab testing to assess metabolic markers Nutritional and lifestyle guidance Ongoing provider support and monitoring GLP-1 medications when clinically appropriate This structured model supports steady, maintainable progress rather than rapid cycles of loss and regain
18 Obesity is an important contributor to the pathophysiology of both diabetes and HF, particularly HFpEF
Synergistic Blends Many labs are now exploring the combination of GLP-1 with other incretins, such as GIP (Glucose-dependent Insulinotropic Polypeptide)
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines key variants in GLP-1 receptor pathways, including FTO rs9939609, GIPR rs1800437, and MC4R rs17782313
Thats published research going back to 1992